Granules India Ltd. (GRANULES): Granules India Share Price rises 2.86% to Rs 855 in today’s trade
- September 3, 2026
- Posted by: Harsh Piplani
- Category: News
Granules India Share Price is trading at Rs 855, up 2.86% from the previous close of Rs 831.25, with market capitalisation at Rs 20,755.47 Cr. The latest move places Granules India Ltd. among the stocks in news today, even though the verified data confirms the price event but does not establish a company-specific catalyst. For readers tracking Granules India Share Price Today, the key point is simple: the stock is rising today on a measured intraday gain, while the broader market continues to assess valuation and sector context. According to latest Univest data, the move is relevant because the share price rose to the day high at Rs 855 after opening at Rs 834.55, which signals steady early trade rather than a sharp gap move. Univest is also showing that investors can keep an eye on price action, market cap and peer positioning as the next reference points.
Granules India Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 855 |
| Previous Close | Rs 831.25 |
| Today's Move | Rs 23.75 (+2.86%) |
| Open | Rs 834.55 |
| High | Rs 855 |
| Low | Rs 834.55 |
| Turnover | Rs 0.94 crore |
| Market Capitalisation | Rs 20,755.47 crore |
| Market Cap Category | Large Cap |
Granules India Ltd. (GRANULES) rose to Rs 855 from the previous close of Rs 831.25, a move of Rs 23.75 or 2.86%. The stock opened at Rs 834.55, reached a high of Rs 855, recorded a low of Rs 834.55.
Granules India Share Price Today reflects a gain of Rs 23.75, or 2.86%, with the stock last traded at Rs 855. The day opened at Rs 834.55, touched a low of Rs 834.55 and reached a high of Rs 855, so the stock has traded near the upper end of its range so far. With turnover of Rs 0.94 Cr, the move is attracting attention in Granules India Stock News, but the latest Univest figures do not establish a company-specific trigger. For market participants watching Granules India Share Price Live, the session shows orderly price action rather than a disorderly swing. Univest data also indicates that the current move is being watched as part of broader Stock Market Today and Share Market Today sentiment in healthcare names.
Granules India Ltd. (GRANULES) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 20,755.47 crore |
| P/E Ratio | 31.1x |
| P/B Ratio | 4.2x |
| ROE | 14.13% |
| ROCE | 15.74% |
| EPS | Rs 26.73 |
| Book Value Per Share | Rs 197.72 |
| Dividend Yield | 0.21% |
Granules India Ltd. (GRANULES) fundamental metrics show P/E 31.1x, P/B 4.2x, ROE 14.13%, ROCE 15.74%. These figures provide context only and are not a buy or sell signal.
Granules India Ltd. has a market capitalisation of Rs 20755.47 crore and falls in the Large Cap category, which gives readers a sense of company size before judging valuation. On valuation, P/E at 31.1x, P/B at 4.2x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 14.13% and ROCE of 15.74%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 26.73, book value per share of Rs 197.72, dividend yield of 0.21%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 31.97x, median ROE of 11.79%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 31.1x |
| Benchmark Median P/E | 31.97x |
| Benchmark Average P/E | 48.6x |
| Benchmark P/E Range | 3.49x to 648.54x |
| Company P/B Ratio | 4.2x |
| Benchmark Median P/B | 2.87x |
| Company ROE | 14.13% |
| Benchmark Median ROE | 11.79% |
| Company ROCE | 15.74% |
| Benchmark Median ROCE | 13.63% |
| Company Market Capitalisation | Rs 20,755.47 crore |
| Benchmark Median Market Cap | Rs 727.27 crore |
Granules India Ltd. (GRANULES) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.
Granules India Ltd. (GRANULES) has a P/E ratio of 31.1x, which is below the benchmark median of 31.97x, a difference of -2.72%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.
Granules India Ltd. (GRANULES) has a ROE of 14.13%, which is above the benchmark median of 11.79%, a difference of +19.85%. Granules India Ltd. (GRANULES) has a ROCE of 15.74%, which is above the benchmark median of 13.63%, a difference of +15.48%.
Track stocks leading today through the Univest top gainers screener. The peer table below provides the company-level comparison.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | SUNPHARMA | 4,63,179.62 | 38.34 | 5.36 | 14.85 | 19.11 |
| Divi's Laboratories Ltd. | DIVISLAB | 2,43,301.95 | 83.79 | 13.88 | 16.19 | 21.51 |
| Torrent Pharmaceuticals Ltd. | TORNTPHARM | 1,88,622.52 | 87.28 | 21.21 | 26.76 | 19.27 |
| Zydus Lifesciences Ltd. | ZYDUSLIFE | 1,16,114.43 | 25.44 | 4.26 | 19.69 | 21.39 |
| Cipla Ltd. | CIPLA | 1,14,554.33 | 33.87 | 3.25 | 11.83 | 16 |
Granules India Ltd. (GRANULES) has a P/E ratio of 31.1x compared with the displayed peer median of 38.34x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 14.13% compares with a peer median of 16.19% across the companies shown in the table. ROCE stood at 15.74% versus the displayed peer median of 19.27%, providing a capital-efficiency comparison. Granules India Ltd. (GRANULES) has a market capitalisation of Rs 20,755.47 crore. Among the 5 peers shown, 5 have a larger market capitalisation.
Why Investors Are Watching Granules India
- Granules India Share Price is rising today by 2.86%, which keeps it in Granules India Stock News and Top Gainers Today discussions.
- The stock traded from Rs 834.55 to Rs 855, so recent Price Action has been orderly and easy to track on Univest.
- Granules India Fundamental Analysis shows P/E, P/B, ROE and ROCE that are all relevant against the healthcare sector benchmark.
- Granules India Market Cap of Rs 20,755.47 Cr places it in a mid-sized peer set within Pharmaceuticals & Drugs.
- Granules India Stock Performance can be compared with healthcare peers where valuation and return ratios vary widely.
About Granules India
Granules India Ltd. is part of the Healthcare sector and operates in Pharmaceuticals & Drugs. The business is known for pharmaceutical manufacturing and related product lines that feed into the broader Indian healthcare supply chain. For investors tracking Granules India Company News, the company’s market profile matters because the share price often reflects both earnings delivery and sector sentiment. Granules India Share News is therefore not only about a daily move in the stock; it also reflects how the market reads its valuation, capital efficiency and earnings profile. With a market cap of Rs 20,755.47 Cr, the company sits above the typical industry median size, making it large enough to be watched closely but still smaller than the sector’s biggest names. That positioning helps explain why Granules India Share Price Today can attract both active traders and longer-term sector watchers.
Frequently Asked Questions
Why is Granules India Share Price rising today?
Ans. Granules India Share Price is rising today because the stock is up 2.86% at Rs 855. The latest Univest figures confirm the move, but they do not establish a company-specific catalyst for the gain.
What is the current Granules India Share Price today?
Ans. Granules India Share Price today is Rs 855. It is up Rs 23.75 from the previous close of Rs 831.25, placing the stock among the day’s active healthcare movers on Univest.
What is Granules India market cap?
Ans. Granules India Market Cap stands at Rs 20,755.47 Cr. That size places the company well above the industry median in the same-industry benchmark and gives context to its valuation and peer comparisons.
How does Granules India valuation compare with peers?
Ans. Granules India trades at a P/E of 31.1 and P/B of 4.2. Compared with peers, it is cheaper than several premium pharma names on earnings multiples and roughly in line on book-value multiples.
What do Granules India ROE and ROCE indicate?
Ans. Granules India reports ROE of 14.13% and ROCE of 15.74%. Both are above the same-industry medians, which suggests the company is generating returns that compare favourably with the broader healthcare set.
What do EPS and book value show for Granules India?
Ans. Granules India has EPS of Rs 26.73 and book value of Rs 197.72. EPS shows earnings per share, while book value gives an accounting reference for what each share is backed by.
Is Granules India part of the healthcare sector?
Ans. Yes. Granules India belongs to the Healthcare sector and the Pharmaceuticals & Drugs industry. That places the stock within a large benchmark universe where pricing, returns and valuation can be compared across many peers.
Should investors track Granules India Share Price on Univest?
Ans. Investors tracking Granules India Share Price can use Univest for live updates, valuation ratios, market cap, earnings metrics and sector comparison. It is useful for monitoring how the stock behaves relative to healthcare peers.
Track Granules India Share Price on Univest
Use Granules India Ltd. (GRANULES) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top-gainers lists and related market analysis.
Track Granules India Share Price on Univest to follow live price updates, stock performance, valuation ratios, sector context and company news in one place. Univest also helps users review Granules India Share Price Today alongside market cap, earnings ratios, book value, dividend yield and broader pharma-sector comparisons. For those following Granules India Latest News, Univest keeps the stock story organised around facts rather than noise.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
